Bioprospecting of Natural Compounds from Brazilian Cerrado Biome Plants in Human Cervical Cancer Cell Lines.

Marcela N Rosa, Larissa R V E Silva, Giovanna B Longato, Adriane F Evangelista, Izabela N F Gomes, Ana Laura V Alves, Bruno G de Oliveira, Fernanda E Pinto, Wanderson Romão, Allisson R de Rezende, Arali A C Araújo, Lohanna S F M Oliveira, Alessandra A de M Souza, Stephanie C Oliveira, Rosy Iara M de A Ribeiro, Viviane A O Silva, Rui M Reis

Journal: International journal of molecular sciences 2021;22(7):3383

PMID: 33806119

Abstract

Cervical cancer is the third most common in Brazilian women. The chemotherapy used for the treatment of this disease can cause many side effects; then, to overcome this problem, new treatment options are necessary. Natural compounds represent one of the most promising sources for the development of new drugs. In this study, 13 different species of 6 families from the Brazilian Cerrado vegetation biome were screened against human cervical cancer cell lines (CCC). Some of these species were also evaluated in one normal keratinocyte cell line (HaCaT). The effect of crude extracts on cell viability was evaluated by a colorimetric method (MTS assay). Extracts from , , , , , , and showed half-maximal inhibitory concentration (IC) values < 30 μg/mL for at least one CCC. and extracts were selective for CCC. Mass spectrometry (Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometer (ESI FT-ICR MS)) of identified fatty acids and flavonols as secondary compounds. One of the fractions, 7C24 (from chloroform partition), increased H2AX phosphorylation (suggesting DNA damage), PARP cleavage, and cell cycle arrest in CCC. Kaempferol-3-O-rhamnoside and oleic acid were bioactive molecules identified in 7C24 fraction. These findings emphasize the importance of investigating bioactive molecules from natural sources for developing new anti-cancer drugs.

Address: Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.; Research Laboratory in Molecular Pharmacology and Bioactive Compounds, São Francisco University, Bragança Paulista 12916-900, Brazil.; Petroleomic and Forensic Laboratory, Chemistry Department, Federal University of Espírito Santo, Vitória 29075-910, Brazil.; Higher Institute of Education and Research of Ituiutaba, University of the State of Minas Gerais (UEMG), Ituiutaba 38302-192, Brazil.; Laboratory of Experimental Pathology, Federal University of São João del Rei-CCO/UFSJ, Divinópolis 35501-296, Brazil.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga, Portugal.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.